retinosis.org

la rp en español

Buscar en el sitio principal de retinosis.org



Secciones en el sitio principal de retinosis.org




Boletí­n Informativo Mayo
Miércoles, 1 de Junio de 2011

Retina Noticias

CONTENIDOS

Artí­culos Cientí­ficos

Noticias

Agenda (jornadas, congresos, seminarios, conferencias, cursos)

ARTíCULOS CIENTíFICOS

  • Retinal specific measurement of dark-adapted visual function: validation of a modified microperimeter

  • Texto completo

  • Transplantation of Adult Mouse iPS Cell-Derived Photoreceptor Precursors Restores Retinal Structure and Function in Degenerative Mice

  • Texto completo

  • Age-Related Retinopathy in NRF2-Deficient Mice

  • Texto completo

  • A Non Membrane-Targeted Human Soluble CD59 Attenuates Choroidal Neovascularization in a Model of Age Related Macular Degeneration

  • Texto completo

  • Interleukin and Growth Factor Levels in Subretinal Fluid in Rhegmatogenous Retinal Detachment: A Case-Control Study

  • Texto completo

  • Mouse Mutants for the Nicotinic Acetylcholine Receptor íŸ2 Subunit Display Changes in Cell Adhesion and Neurodegeneration Response Genes

  • Texto completo

  • Mature Peripheral RPE Cells Have an Intrinsic Capacity to Proliferate; A Potential Regulatory Mechanism for Age-Related Cell Loss

  • Texto completo

  • Multidimensional Scaling Reveals the Main Evolutionary Pathways of Class A G-Protein-Coupled Receptors

  • Texto completo

  • Influence of Dll4 via HIF-1a-VEGF Signaling on the Angiogenesis of Choroidal Neovascularization under Hypoxic Conditions

  • Texto completo

  • Association between the SERPING1 Gene and Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Japanese

  • Texto completo

  • A Therapeutic Chemical Chaperone Inhibits Cholera Intoxication and Unfolding/Translocation of the Cholera Toxin A1 Subunit

  • Texto completo

  • Human Cytomegalovirus IE1 Protein Elicits a Type II Interferon-Like Host Cell Response That Depends on Activated STAT1 but Not Interferon-y

  • Texto completo

  • Efficacious and Safe Tissue-Selective Controlled Gene Therapy Approaches for the Cornea

  • Texto completo

  • Association of Retinal and Macular Damage with Brain Atrophy in Multiple Sclerosis

  • Texto completo

  • Drosophila Photoreceptor Cells Exploited for the Production of Eukaryotic Membrane Proteins: Receptors, Transporters and Channels

  • Texto completo

  • Yeast Two Hybrid Analyses Reveal Novel Binary Interactions between Human Cytomegalovirus-Encoded Virion Proteins

  • Texto completo

  • Inhibition of Reactive Gliosis Attenuates Excitotoxicity-Mediated Death of Retinal Ganglion Cells

  • Texto completo

  • Subretinal gene delivery using helper-dependent adenoviral vectors

  • Abstract

  • Atherosclerotic and Thrombophilic Risk Factors in Patients With Ischemic Central Retinal Vein Occlusion

  • Abstract

  • Twenty-Three”“Gauge Pars Plana Vitrectomy, Densiron-68, and 360° Endolaser Versus Combined 20-Gauge Pars Plana Vitrectomy, Scleral Buckle, and Sf6 for Pseudophakic Retinal Detachment With Inferior Retinal Breaks

  • Abstract

  • Macular Thickness Measurements in Central Retinal Artery Occlusion By Optical Coherence Tomography

  • Abstract

  • Detection and Monitoring of Sickle Cell Retinopathy Using Ultra Wide-Field Color Photography and Fluorescein Angiography

  • Abstract

  • Subretinal Dot-Like Precipitates and Yellow Material in Central Serous Chorioretinopathy

  • Abstract

  • AAV Mediated GDNF Secretion From Retinal Glia Slows Down Retinal Degeneration in a Rat Model of Retinitis Pigmentosa

  • Abstract

  • High transcriptional complexity of the retinitis pigmentosaCERKL gene in human and mouse.

  • Abstract

  • N-acetylcysteine promotes long-term survival of cones in a model of retinitis pigmentosa.

  • Abstract

  • Optical coherence tomographic parameters as objective signs for visual acuity in patients with retinitis pigmentosa, future candidates for retinal prostheses

  • Abstract

  • Homozygosity mapping identifies the Crumbs homologue 1 (Crb1) gene as responsible for a recessive syndrome of retinitis pigmentosa and nanophthalmos.

  • Abstract

  • Oncostatin m protects rod and cone photoreceptors and promotes regeneration of cone outer segment in a rat model of retinal degeneration

  • Abstract

  • Efficient mutagenesis of the rhodopsin gene in rod photoreceptor neurons in mice.

  • Abstract

  • Retinal dystrophy in Bardet-Biedl syndrome and related syndromic ciliopathies.

  • Abstract

  • Pigmentary Glaucoma Accompanied by Usher Syndrome

  • Abstract

  • Transcorneal Electrical Stimulation for Patients with Retinitis Pigmentosa — a Prospective, Randomized, Sham-Controlled Exploratory Study.

  • Abstract

  • Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study

  • Abstract

  • A Phase 1 Study of KH902, a Vascular Endothelial Growth Factor Receptor Decoy, for Exudative Age-Related Macular Degeneration

  • Abstract

  • Progression of Geographic Atrophy in Age-Related Macular Degeneration Imaged with Spectral Domain Optical Coherence Tomography

  • Abstract

  • Documentation of Intraretinal Retinal Pigment Epithelium Migration via High-Speed Ultrahigh-Resolution Optical Coherence Tomography

  • Abstract

  • Healthy Lifestyles Related to Subsequent Prevalence of Age-Related Macular Degeneration

  • Abstract

    NOTICIAS

  • La pérdida de visión disminuye con la terapia de células encapsuladas

    Un ensayo clí­nico de fase 2 para el tratamiento de una forma grave de la degeneración macular relacionada con la edad llamada atrofia geográfica (GA) se ha convertido en el primer estudio que muestra el beneficio de una terapia para frenar la progresión de la pérdida de la visión de esta enfermedad. Los resultados ponen de manifiesto el beneficio de la utilización de un factor neurotrófico para tratarla y dar esperanza a casi un millón de estadounidenses que sufren GA.
    Noticia completa

  • ProRetina, GP Pharm y BCN Peptides, juntas en I+D de retinosis

    La compañí­a ProRetina -spin-off del Centro de Investigaciones Biológicas del CSIC-, la biofarmacéutica GP Pharm y BCN Peptides -división de quí­mica fina de Lipotec- han formado un consorcio para el desarrollo de formulaciones que permitan vehicular fármacos a la retina.
    Noticia completa

  • Dos proteí­nas de la retina se asocian al exceso de amiloide

    Dos proteí­nas clave para el desarrollo de la retina podrí­an contribuir a la formación de depósitos de amiloide.
    Noticia completa

  • Los cientí­ficos crean retinas en laboratorio a partir de células madre

    En una investigación que representa un hito en el campo de las células madre, cientí­ficos de Japón han conseguido crear retinas en laboratorio a partir de células embrionarias.
    Noticia completa

  • Hallan indicios sobre la influencia de células nerviosas en la degeneración de la retina

    Un grupo de investigadores del departamento de Biologí­a Celular de la Universidad de Granada ha descubierto indicios de la influencia de las células microgliales en la muerte de células fotorreceptoras, que son las encargadas de convertir la luz en señales reconocibles por las neuronas.
    Noticia completa

  • Nace la Fundación IMO para promover la investigación cientí­fica en Oftalmologí­a

    El Instituto de Microcirugí­a Ocular de Barcelona (IMO) ha creado una fundación destinada a promover la investigación cientí­fica básica en Oftalmologí­a y mejorar así­ la visión de los pacientes.
    Noticia completa

  • Gene therapy shows promise against age-related macular degeneration

    A study shows promise in slowing age-related macular degeneration (AMD). Tufts researchers demonstrate for the first time that a gene therapy approach to deliver CD59, an inhibitor of complement, can significantly reduce uncontrolled blood vessel growth and cell death that is typical in AMD, the most common cause of blindness in the elderly
    Noticia completa

  • Artificial Retinal Implants Must Adapt to Unique Features of Human Eye to Be Effective, Experts Say

    In the May issue of Physics World, Richard Taylor, professor of physics, psychology and art at the University of Oregon, warns that artificial retinal implants — a technology fast becoming a reality — must adapt to the unique features of the human eye in order to become an effective treatment.
    Noticia completa

  • Avastin and Lucentis Are Equally Effective in Treating Age-Related Macular Degeneration (AMD), Study Suggests

    Researchers are reporting results from the first year of a two-year clinical trial that Avastin, a drug approved to treat some cancers and that is commonly used off-label to treat age-related macular degeneration (AMD), is as effective as the Food and Drug Administration-approved drug Lucentis for the treatment of AMD.
    Noticia completa

  • Vision Loss in Eye Disease Slowed Using Novel Encapsulated Cell Therapy

    A phase 2 clinical trial for the treatment of a severe form of age-related macular degeneration called geographic atrophy (GA) has become the first study to show the benefit of a therapy to slow the progression of vision loss for this disease. The results highlight the benefit of the use of a neurotrophic factor to treat GA and provide hope to nearly one million Americans suffering from GA.
    Noticia completa

  • Second Sight Medical Products Announces European Market Approval Of A Retinal Prosthesis For The Blind

    After more than 20 years of research and development involving a team of international specialists, Second Sight Medical Products, Inc., the leading developer of retinal prostheses for the blind, is pleased to announce that its Argus II Retinal Prosthesis System (“Argus II”) is now approved for sale in the European Economic Area (EEA).
    Noticia completa

  • Promedior Announces Presentation Of Data At ARVO Demonstrating That PRM-151 (rhPTX-2) Suppresses Choroidal And Retinal Neovascularization

    Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic, inflammatory and neovascular diseases, today announced that data from preclinical studies of PRM-151 (recombinant human Pentraxin-2 (PTX-2)) will be presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), being held May 1-5, 2011 in Ft. Lauderdale, FL.
    Noticia completa

  • Pig Stem Cell Transplants: The Key To Future Research Into Retina Treatment

    A team of American and Chinese scientists studying the role of stem cells in repairing damaged retina tissue have found that pigs represent an effective proxy species to research treatments for humans. The study, published in Stem Cells, demonstrates how cells can be isolated and transplanted between pigs, overcoming a key barrier to the research
    Noticia completa

  • PDMS and PFO is effective as tamponade

    A study published in Clinical Ophthalmology has proved the efficacy of using polydimethyloxane (PDMS) and perfluoro-n-octane (PFO) as tamponade in patients with retinal detachment complicated by proliferative vitreoretinopathy (PVR).
    Noticia completa

  • AGENDA

  • 24th International Congress of German Ophthalmic Surgeons
  • Fecha:desde el 19/05/11 hasta 22/05/11

    Dónde:Nuremberg, Germany

    Web:DOC 2011

  • Presbymania 2011
  • Fecha: 03/06/11

    Dónde:Geneva, Switzerland

    Web:Presbymania

  • Joint Congress of SOE and the AAO
  • Fecha: 03/06/11

    Dónde:Geneva, Switzerland

    Web:SOE 2011

    Deja tu comentario